AOP Health
Krejcy Kurt has held various positions in the pharmaceutical industry, including Chief Medical Officer at AOP Orphan Pharmaceuticals AG since 2017. Prior to that, krejcy served as Head International Medical Affairs at the same company in 2016. Kurt also has extensive experience as the Medical Director Oncology Europe at Eli Lilly from 1995 to 2015.
This person is not in any offices
AOP Health
1 followers
Previously known as AOP Orphan, AOP Health is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the company has become an established provider of integrated therapy solutions from its headquarters in Vienna, its subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide. This development has been made possible by a continually high level of investment in research and development on the one hand and a highly consistent and pragmatic orientation towards the needs of all our stakeholders on the other - especially the patients and their families as well as also the doctors and care professionals treating them. Needs. Science. Trust. The international healthcare group focuses on research, development and global sales of innovative treatment solutions. AOP Health believes it has a responsibility to make innovative integrated therapies and disease-management solutions available long term to as many patients as possible who suffer from rare diseases or require critical care. Data protection information: https://www.aop-health.com/global_en/footer/privacy-policy